How much total funding has ASEMtech secured in its entire Series A round as of March 2026?

Combined with the 250 million yen raised in April 2025, ASEMtech has achieved a total of 400 million yen in funding for the entire Series A round.

Which financial institutions participated in ASEMtech's Series A extension round?

Participants in the Series A extension round include Hanno Shinkin Bank, Tama Shinkin Bank, BP Capital Co., Ltd. (TUAT Fund No. 1), and Leo Denshi Co., Ltd.

What milestone did ASEMtech achieve regarding clinical research with its medical device prototype?

ASEMtech completed a medical device prototype and began clinical research targeting musculoskeletal disorders at university hospitals using the ASEM method.

What regulatory authorization has ASEMtech obtained for its medical device development?

ASEMtech has obtained a Class II Medical Device Marketing Authorization, strengthening its regulatory application and quality management systems.

AI News NQ Analysis

ASEMtech Raises 150 Million Yen in Series A Extension Round

NQ Score 50/100

AI Summary (NQ-processed)

ASEMtech, a company developing Acoustically Stimulated Electromagnetic (ASEM) technology, has raised 150 million yen in a Series A extension round, bringing its total Series A funding to 400 million yen. The funds will accelerate clinical research for medical applications, regulatory approval processes, and the expansion of its industrial non-destructive testing business.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What company raised 150 million yen in a Series A extension round in March 2026?: A: ASEMtech Co., Ltd. raised 150 million yen through a third-party allotment of shares in a Series A extension round conducted in March 2026.
Q: How much total funding has ASEMtech secured in its entire Series A round as of March 2026?: A: Combined with the 250 million yen raised in April 2025, ASEMtech has achieved a total of 400 million yen in funding for the entire Series A round.
Q: Which financial institutions participated in ASEMtech's Series A extension round?: A: Participants in the Series A extension round include Hanno Shinkin Bank, Tama Shinkin Bank, BP Capital Co., Ltd. (TUAT Fund No. 1), and Leo Denshi Co., Ltd.
Q: What milestone did ASEMtech achieve regarding clinical research with its medical device prototype?: A: ASEMtech completed a medical device prototype and began clinical research targeting musculoskeletal disorders at university hospitals using the ASEM method.
Q: What regulatory authorization has ASEMtech obtained for its medical device development?: A: ASEMtech has obtained a Class II Medical Device Marketing Authorization, strengthening its regulatory application and quality management systems.